3rd Quarter - Report

LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to affordability and pricing of pharmaceuticals including S.771 Improving Access to Affordable Prescription Drugs Act. FDA user fee agreements, including the Prescription Drug User Fee Agreement and the Generic Drug User Fee Agreement. Issues related to H.R. 1628, the American Health Care Act. Better Care Reconciliation Act (BCRA) Issues related to opioids

LobbyistCovered position, as disclosed
GINGER LOPER Special Assistant to the President for Legislative Affairs (2002-2005)

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: S. 771 (115th), H.R. 1628 (115th)

Medicare/Medicaid MMM

Medicaid rebate CPI drug pricing issues

LobbyistCovered position, as disclosed
GINGER LOPER Special Assistant to the President for Legislative Affairs (2002-2005)

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.